Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin PR vs Clonazepam for RBD in Parkinson's Disease
NCT02789592Phase 2Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in REM sleep behavior disorder (RBD), sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
melatonin
03
Conditions
REM sleep behavior disorder (RBD)
Beyond the preview
Go deeper on NCT02789592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02789592.